Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Reshaping Dosage Forms

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Frontrunners in Bispecific Antibodies

Topic

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

Articles

GE Healthcare's partnerships with iBio and Brazil's Bio-Manguinhos/Fiocruz for a new plant-based multipurpose biopharmaceutical and vaccine manufacturing facility move plant-based protein production to the next level.

GE Healthcare, iBio, and Bio-Manguinhos/Fiocruz Advance Large-Scale Plant-Based Protein Production

The EMA's Committee for Medicinal Products for Human Use has recommended granting of marketing authorizations for the first two monoclonal antibody biosimilars.

CHMP Recommends Approval of First Two mAb Biosimilars

Since its inception in 2011, Fujifilm Diosynth Biotechnologies has added capabilities and single-use production capacity for mammalian-derived product manufacturing, upgraded development and pilot-scale microbial laboratories, and installed advanced analytical instrumentation.

Fujifilm Diosynth Biotechnologies in an Expansion Mode

The benefits of single-use systems are being realized for downstream unit operations, including aseptic filling.

Aseptic Filling is the Next-Generation Application for Single-Use Systems

Global program seeks to confirm biosimilarity to support regulatory submissions in the US and EU.

Sandoz Launches Phase III Clinical Trial for Biosimilar Etanercept

A conversation with Kevin Brady of Alkermes about how high potency APIs are changing the way drugs are developed and manufactured in terms of process, equipment and regulations, including a case study that demonstrates the effective scale up or manufacture of a drug with a highly potent API.

High Potency APIs Video

A screening method predicts delamination in primary packaging.

Evaluating Parenteral Packaging for Glass Delamination

Semi-automatic technology aids egg-based influenza vaccine production in smaller facility footprints.

RAME-HART Technology Helps Boost Vaccine Production in Emerging Markets

PSL has developed a microsphere refiner for microsphere formulation, from small scale processes to commercial production.

PSL Develops Microsphere Refiner for Formulation of Microspheres

Aseptic connectors provide the flexibility and robustness needed for modern parenteral manufacturing operations.